TargetMol

Orforglipron - GLP-1 receptor agonist 1

Product Code:
 
TAR-T11408
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T11408-1mg1mg£856.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T11408-5mg5mg£2,601.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T11408-10mg10mg£3,934.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T11408-25mg25mg£5,797.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T11408-50mg50mg£7,805.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T11408-100mg100mg£10,352.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
GLP-1 receptor agonist 1 is a GLP-1 receptor agonist .
CAS:
2212020-52-3
Formula:
C48H48F2N10O5
Long Description:
GLP-1RA and SGLT-2i are new diabetes medications that have gained widespread attention due to their cardiovascular and renal benefits brought to patients with type 2 diabetes (T2D). Orforglipron, also known as LY3502970, is a GLP-1 receptor agonist. It is used in research related to obesity and T2D.
Molecular Weight:
882.974
Pathway:
GPCR/G Protein
Purity:
0.98
Research Area:
Obesity , T2D
SMILES:
C[C@H]1C[C@]1(c1noc(=O)[nH]1)n1c(cc2cc(ccc12)[C@H]1CCOC(C)(C)C1)C(=O)N1CCc2nn(c(c2[C@@H]1C)-n1ccn(-c2ccc3n(C)ncc3c2F)c1=O)-c1cc(C)c(F)c(C)c1
Target:
Glucagon Receptor

References

1. Pyrazolopyridine derivative having glp-1 receptor agonist effect. WO2013046136A1.